Lizabeth A. Bourret

1.5k total citations
18 papers, 1.3k citations indexed

About

Lizabeth A. Bourret is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Lizabeth A. Bourret has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Lizabeth A. Bourret's work include Osteoarthritis Treatment and Mechanisms (5 papers), RNA Interference and Gene Delivery (3 papers) and Bone fractures and treatments (3 papers). Lizabeth A. Bourret is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), RNA Interference and Gene Delivery (3 papers) and Bone fractures and treatments (3 papers). Lizabeth A. Bourret collaborates with scholars based in United States. Lizabeth A. Bourret's co-authors include Gideon A. Rodan, Louis Arthur Norton, J. Fred Dice, Victor S. Goldmacher, Alan R. Harvey, Nancy Kedersha, J.P. Veldhuijzen, Pengfei Miao, Nicola T. Neff and W A Blättler and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Lizabeth A. Bourret

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizabeth A. Bourret United States 13 554 233 206 196 192 18 1.3k
Frances B. Cannon United States 7 933 1.7× 140 0.6× 339 1.6× 108 0.6× 504 2.6× 7 2.1k
Zafrira Avnur United States 18 728 1.3× 93 0.4× 256 1.2× 67 0.3× 545 2.8× 20 1.6k
A. Johnsson Sweden 13 964 1.7× 149 0.6× 323 1.6× 64 0.3× 201 1.0× 15 1.7k
H. J. Altermatt Switzerland 20 695 1.3× 124 0.5× 643 3.1× 53 0.3× 86 0.4× 53 1.9k
Sandra L. Biroc United States 15 733 1.3× 185 0.8× 574 2.8× 108 0.6× 142 0.7× 22 1.4k
David A. Sampson United States 12 371 0.7× 52 0.2× 254 1.2× 81 0.4× 75 0.4× 23 1.1k
Susanne Pippig United States 21 1.0k 1.9× 111 0.5× 194 0.9× 51 0.3× 146 0.8× 24 2.0k
David H. Rohrbach United States 11 399 0.7× 102 0.4× 100 0.5× 55 0.3× 389 2.0× 19 1.2k
M. Lourdes Ponce United States 18 900 1.6× 101 0.4× 566 2.7× 75 0.4× 233 1.2× 19 2.0k
Piia Valonen Finland 23 356 0.6× 269 1.2× 51 0.2× 235 1.2× 56 0.3× 34 1.1k

Countries citing papers authored by Lizabeth A. Bourret

Since Specialization
Citations

This map shows the geographic impact of Lizabeth A. Bourret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizabeth A. Bourret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizabeth A. Bourret more than expected).

Fields of papers citing papers by Lizabeth A. Bourret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizabeth A. Bourret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizabeth A. Bourret. The network helps show where Lizabeth A. Bourret may publish in the future.

Co-authorship network of co-authors of Lizabeth A. Bourret

This figure shows the co-authorship network connecting the top 25 collaborators of Lizabeth A. Bourret. A scholar is included among the top collaborators of Lizabeth A. Bourret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizabeth A. Bourret. Lizabeth A. Bourret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chari, Ravi, et al.. (1997). Folate‐maytansinoids: Target‐selective drugs of low molecular weight. International Journal of Cancer. 73(6). 859–864. 105 indexed citations
2.
Chari, Ravi, et al.. (1997). Folate‐maytansinoids: Target‐selective drugs of low molecular weight. International Journal of Cancer. 73(6). 859–864. 1 indexed citations
3.
Tadayoni, B. Mitra, Lizabeth A. Bourret, Wayne C. Widdison, et al.. (1996). Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.. Proceedings of the National Academy of Sciences. 93(16). 8618–8623. 146 indexed citations
4.
CHARI, R. V. J., Lizabeth A. Bourret, B. Mitra Tadayoni, et al.. (1995). Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation.. PubMed. 55(18). 4079–84. 84 indexed citations
5.
Shah, Sudhir, et al.. (1993). Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.. PubMed. 53(6). 1360–7. 41 indexed citations
6.
Bell, R. S., Lizabeth A. Bourret, Deborah F. Bell, et al.. (1988). Evaluation of fluorescein diacetate for flow cytometric determination of cell viability in orthopaedic research. Journal of Orthopaedic Research®. 6(4). 467–474. 26 indexed citations
7.
Miao, Pengfei, et al.. (1985). Regulation of catabolism of ribonuclease A microinjected into human fibroblasts.. PubMed. 180. 385–94. 6 indexed citations
8.
Backer, Joseph M., Lizabeth A. Bourret, & J. Fred Dice. (1983). Regulation of catabolism of microinjected ribonuclease A requires the amino-terminal 20 amino acids.. Proceedings of the National Academy of Sciences. 80(8). 2166–2170. 69 indexed citations
9.
Neff, Nicola T., Lizabeth A. Bourret, Pengfei Miao, & J. Fred Dice. (1981). Degradation of proteins microinjected into IMR-90 human diploid fibroblasts.. The Journal of Cell Biology. 91(1). 184–194. 108 indexed citations
10.
Veldhuijzen, J.P., Lizabeth A. Bourret, & Gideon A. Rodan. (1979). In Vitro studies of the effect of intermittent compressive forces on cartilage cell proliferation. Journal of Cellular Physiology. 98(2). 299–306. 93 indexed citations
11.
Bourret, Lizabeth A., Paul F. Goetinck, Raymond L. Hintz, & Gideon A. Rodan. (1979). Cyclic 3′,5′‐AMP changes in chondrocytes of the proteoglycan‐deficient chick embryonic mutant, nanomelia. FEBS Letters. 108(2). 353–355. 7 indexed citations
12.
Rodan, Gideon A., Lizabeth A. Bourret, & Louis Arthur Norton. (1978). DNA Synthesis in Cartilage Cells Is Stimulated by Oscillating Electric Fields. Science. 199(4329). 690–692. 181 indexed citations
13.
Rodan, Gideon A., Lizabeth A. Bourret, & Leslie S. Cutler. (1977). Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase.. The Journal of Cell Biology. 72(2). 493–501. 49 indexed citations
14.
Norton, Louis Arthur, Gideon A. Rodan, & Lizabeth A. Bourret. (1977). Epiphyseal Cartilage cAMP Changes Produced by Electrical and Mechanical Perturbations. Clinical Orthopaedics and Related Research. 124(124). 59–68. 89 indexed citations
15.
Bourret, Lizabeth A. & Gideon A. Rodan. (1976). The role of calcium in the inhibition of cAMP accumulation in epiphyseal cartilage cells exposed to physiological pressure. Journal of Cellular Physiology. 88(3). 353–361. 66 indexed citations
16.
Bourret, Lizabeth A. & Gideon A. Rodan. (1976). Inhibition of cAMP Accumulation in Epiphyseal Cartilage Cells Exposed to Physiological Pressure. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21 Suppl. 431–436. 10 indexed citations
17.
Bourret, Lizabeth A. & Gideon A. Rodan. (1975). Inhibition of cAMP accumulation in epiphyseal cartilage cells exposed to physiological pressure. Calcified Tissue International. 21(1). 431–436. 10 indexed citations
18.
Rodan, Gideon A., et al.. (1975). Cyclic AMP and Cyclic GMP: Mediators of the Mechanical Effects on Bone Remodeling. Science. 189(4201). 467–469. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026